A proof-of-concept study to evaluate the antiinflammatory effects of a novel soluble cyclodextrin formulation of nebulized budesonide in patients with mild to moderate asthma

Peter A. Williamson, Daniel Menzies, Arun Nair, Ahmet Tutuncu, Brian J. Lipworth

    Research output: Contribution to journalArticle

    9 Citations (Scopus)

    Abstract

    A cyclodextrin solution formulation of budesonide has been developed.
    Original languageEnglish
    Pages (from-to)161-7
    Number of pages7
    JournalAnnals of Allergy, Asthma & Immunology
    Volume102
    Issue number2
    DOIs
    Publication statusPublished - 2009

    Fingerprint Dive into the research topics of 'A proof-of-concept study to evaluate the antiinflammatory effects of a novel soluble cyclodextrin formulation of nebulized budesonide in patients with mild to moderate asthma'. Together they form a unique fingerprint.

  • Cite this